PharmiWeb.com - Global Pharma News & Resources
04-Apr-2019

Polyphor to present data on murepavadin and its lead preclinical compound of its novel class of Gram-negative antibiotics at the 29th European Congress of Clinical Microbiology and Infectious Diseases

EQS Group-News: Polyphor AG / Key word(s): Conference





Additional features:

Document: http://n.eqs.com/c/fncls.ssp?u=VAGWUEEYUN
Document title: Polyphor_ECCMID


End of Corporate News


Language: English
Company: Polyphor AG
Hegenheimermattweg 125
4123 Allschwil
Switzerland
Phone: +41 61 567 1600
Fax: +41 61 567 1601
E-mail: info@polyphor.com
Internet: www.polyphor.com
ISIN: CH0106213793
Listed: SIX Swiss Exchange
EQS News ID: 795701

 
End of News EQS Group News Service

Editor Details

Last Updated: 04-Apr-2019